Medical research

Messenger RNA: How it works in nature and in making vaccines

Vaccines have long been an integral part of public health programs around the world, reducing the spread and severity of infectious diseases. The success of immunization strategies to protect children from diseases like polio, ...

Vaccination

J&J's HIV vaccine fails in sub-Saharan Africa trial

Johnson & Johnson's highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan Africa, the company and US health authorities said Tuesday.

Vaccination

Glaxo, SK bioscience start final trial of COVID jab

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a COVID-19 jab after positive early results, they announced Tuesday.

Diseases, Conditions, Syndromes

What the Delta variant means for COVID-19

The highly contagious Delta variant has caused a surge in COVID-19 infections and hospitalizations, largely among the unvaccinated. This latest development in the coronavirus pandemic has renewed debates about masking, vaccines ...

Diseases, Conditions, Syndromes

Send vaccines where people want and need them: Developing nations

According to a new study co-authored by Yale's Mushfiq Mobarak and Saad Omer, COVID-19 vaccine acceptance is significantly higher in low- and middle-income countries than wealthy ones. The results suggest that prioritizing ...

page 9 from 34